Literature DB >> 11167100

Perioperative determinants and outcome of cardiopulmonary arrest in children after heart surgery.

P Suominen1, R Palo, H Sairanen, K T Olkkola, J Räsänen.   

Abstract

OBJECTIVES: To identify perioperative factors associated with postoperative cardiopulmonary arrest (CA) in the pediatric intensive care unit (PICU) in children undergoing cardiovascular surgery, and to report the outcome of cardiopulmonary resuscitation (CPR) in these patients.
METHODS: We reviewed the medical records of all patients under 16 years of age who had undergone cardiovascular surgery and sustained CA in PICU in an urban, tertiary care children's hospital over a 5-year period. We used two control groups of patients who recovered without CA. (1) Sixty-five patients, who were operated under deep hypothermic circulatory arrest (DHCA) during the study period. (2) All patients who underwent repair of congenital heart lesions without DHCA in 1994 (n=278).
RESULTS: Eighty-two children experienced CA during postoperative care in PICU, mainly from cardiovascular causes. Thirty-four (41%) were declared dead without attempted resuscitation, CPR was initiated in 48 (59%). The primary survival rate was 56% and 1 year survival rate was 19%. The incidence of CA was 3.6% for closed heart operations, 4.9% for intra-cardiac surgery without DHCA, and 27% for operations involving DHCA. Thirty-three per cent of patients with CA arrested during the first 24 postoperative h. Preoperative mechanical ventilation (P=0.03), prostaglandin E1 (P=0.001) and inotropic support (P=0.04) were given significantly more frequently to patients who postoperatively required CPR, compared to control groups. Patients in whom CPR was attempted were younger than the 1994 controls (0.4 vs. 1.2 years; P<0.04), had longer mean aortic-cross-clamp times (76 vs. 51 min; P<0.0001) and cardiopulmonary bypass times (124 vs. 85 min; P<0.0002), and required more inotropic support upon leaving the operating room (P<0.0001). Patients who received CPR had significantly longer DHCA times (53 vs. 32 min; P<0.0002) and required more inotropic support than patients in the DHCA control group (P<0.002).
CONCLUSIONS: CA after pediatric cardiac surgery is associated with repair of complex congenital heart anomalies in patients who require preoperative mechanical ventilation and vasoactive agents, prolonged aortic cross-clamp, circulatory arrest; and heavy postoperative inotropic support.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11167100     DOI: 10.1016/s1010-7940(00)00650-3

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  4 in total

1.  Epidemiology and Outcomes of Cardiac Arrest in Pediatric Cardiac ICUs.

Authors:  Jeffrey A Alten; Darren Klugman; Tia T Raymond; David S Cooper; Janet E Donohue; Wenying Zhang; Sara K Pasquali; Michael G Gaies
Journal:  Pediatr Crit Care Med       Date:  2017-10       Impact factor: 3.624

2.  Extracorporeal Cardiopulmonary Resuscitation (E-CPR) During Pediatric In-Hospital Cardiopulmonary Arrest Is Associated With Improved Survival to Discharge: A Report from the American Heart Association's Get With The Guidelines-Resuscitation (GWTG-R) Registry.

Authors:  Javier J Lasa; Rachel S Rogers; Russell Localio; Justine Shults; Tia Raymond; Michael Gaies; Ravi Thiagarajan; Peter C Laussen; Todd Kilbaugh; Robert A Berg; Vinay Nadkarni; Alexis Topjian
Journal:  Circulation       Date:  2015-12-03       Impact factor: 29.690

3.  Racial disparities in survival outcomes following pediatric in-hospital cardiac arrest.

Authors:  Sarah E Haskell; Saket Girotra; Yunshu Zhou; M Bridget Zimmerman; Marina Del Rios; Raina M Merchant; Dianne L Atkins
Journal:  Resuscitation       Date:  2021-01-02       Impact factor: 6.251

Review 4.  Global mortality of children after perioperative cardiac arrest: A systematic review, meta-analysis, and meta-regression.

Authors:  Semagn Mekonnen Abate; Solomon Nega; Bivash Basu; Kidanemariam Tamrat
Journal:  Ann Med Surg (Lond)       Date:  2022-02-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.